Cell therapy: Replacement

Stroke

Volumn 34, Issue 8, 2003, Pages 2081-2082

  Wechsler, Lawrence R ^a,b   Kondziolka, Douglas ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Regeneration; Stem cells

Indexed keywords

DOPAMINE;

ANIMAL CELL; AUTOPSY; BRAIN CELL; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN FUNCTION; CELL FUNCTION; CELL LINE; CELL LOSS; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; CELL TRANSPLANTATION; CELL TYPE; CORPUS STRIATUM; DATA ANALYSIS; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; ELECTROENCEPHALOGRAM; FETUS CELL; GLIA CELL; HUMAN; HUMAN CELL; IMMOBILIZED CELL; MESENCEPHALON; NEOCORTEX; NERVE CELL; NERVE FIBER GROWTH; NERVE REGENERATION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL; STROKE; SYNAPSE; TREATMENT OUTCOME;

ANIMALS; BRAIN DISEASES; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CEREBROVASCULAR ACCIDENT; GRAFT SURVIVAL; HUMANS; NEURONS; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 0042122349     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000083461.80316.55     Document Type: Short Survey

References (10)

1. Yandava BD, Billinghurst LL, Snyder EY. "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci U S A. 1999;96: 7029-7034.
2. Herman JP, Abrous ND. Dopaminergic neural grafts after fifteen years: results and perspectives. Pog Neurobiol. 1994;44:1-35.
3. Olanow CW, Freeman T, Kordower J. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001; 345:146; discussion 2001;345:147.
4. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med. 1995;332:1118-1124.
5. Sorensen JC, Grabowski M, Zimmer J, Johansson BB. Fetal neocortical tissue blocks implanted in brain infarcts of adult rats interconnect with the host brain. Exp Neurol. 1996;138:227-235.
6. Kleppner SR, Robinson KA, Trojanowski JQ, Lee VM. Transplanted human neurons derived from a teratocarcinoma cell line (ntera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J Comp Neurol. 1995;357:618-632.
7. Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol. 1998;149:310-321.
8. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, Jannetta P, DeCesare S, Elder EM, McGrogan M, et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology. 2000;55:565-569.
9. Meltzer CC, Kondziolka D, Villemagne VL, Wechsler L, Goldstein S, Thulborn KR, Gebel J, Elder EM, DeCesare S, Jacobs A. Serial [18f] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery. 2001;49:586-591: discussion 2001;49:591-582.
10. Nelson PT, Kondziolka D, Wechsler L, Goldstein S, Gebel J, DeCesare S, Elder EM, Zhang PJ, Jacobs A, McGrogan M, et al. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol. 2002;160:1201-1206.